deCODE Cancer

deCODE Testicular Cancer test

Measures three SNPs to identify 20% of men who are at 40 to 200% above average risk of testicular cancer.


The deCODE Cancer Scan detects the same risk factors and markers included in our individual tests for:

Breast Cancer (deCODE BreastCancer™) and
Prostate Cancer (deCODE ProstateCancer™)

together with:

Basal Cell Carcinoma, Bladder Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Testicular Cancer and Thyroid Cancer.


Testicular Cancer

Screening and prevention

How the deCODE Testicular Cancer test can help.

A first step towards early diagnosis and successful treatment of testicular cancer is helping men to understand their risk, including genetic risk.

This information, and knowledge of signs and symptoms, can make regular self-examination an effective means of detecting cancer early.

The deCODE Cancer Scan detects three SNPs associated with increased risk of developing testicular germ cell tumor (TGCT). They are located near candidate genes BAK1, KITLG and SPRY4 on chromosomes 6, 12 and 5, respectively.

To date, these markers have been replicated and validated only in populations of European descent.

This content was last reviewed on January 26, 2011.